Apellis Pharmaceuticals Eigentümerschaft
Wer sind die Hauptanteilseigner und gab es Insider-Transaktionen?
Jüngste Insider-Transaktionen
Datum | Wert | Name | Entität | Rolle | Aktien | Maximaler Preis |
---|---|---|---|---|---|---|
16 Sep 24 | SellUS$6,952 | James Chopas | Individual | 192 | US$36.21 | |
03 Sep 24 | SellUS$21,720 | James Chopas | Individual | 550 | US$39.49 | |
19 Mar 24 | SellUS$1,068,161 | Epidarex Capital | Company | 18,681 | US$57.18 | |
18 Mar 24 | SellUS$564,050 | Mark Delong | Individual | 9,913 | US$56.90 | |
15 Mar 24 | SellUS$10,389 | James Chopas | Individual | 184 | US$56.46 | |
13 Mar 24 | SellUS$645,838 | Nur Nicholson | Individual | 11,220 | US$58.13 | |
12 Feb 24 | SellUS$40,457 | Mark Delong | Individual | 597 | US$67.77 | |
12 Feb 24 | SellUS$96,974 | Timothy Sullivan | Individual | 1,431 | US$67.77 | |
12 Feb 24 | SellUS$77,796 | Adam Townsend | Individual | 1,148 | US$67.77 | |
12 Feb 24 | SellUS$52,926 | David Watson | Individual | 781 | US$67.77 | |
12 Feb 24 | SellUS$268,492 | Cedric Francois | Individual | 3,962 | US$67.77 | |
12 Feb 24 | SellUS$77,796 | Pascal Deschatelets | Individual | 1,148 | US$67.77 | |
29 Jan 24 | SellUS$23,539 | Mark Delong | Individual | 367 | US$64.14 | |
29 Jan 24 | SellUS$17,895 | Jeffrey Eisele | Individual | 279 | US$64.14 | |
29 Jan 24 | SellUS$182,345 | Cedric Francois | Individual | 2,843 | US$64.14 | |
29 Jan 24 | SellUS$56,057 | Pascal Deschatelets | Individual | 874 | US$64.14 | |
29 Jan 24 | SellUS$58,109 | Adam Townsend | Individual | 906 | US$64.14 | |
29 Jan 24 | SellUS$58,109 | David Watson | Individual | 906 | US$64.14 | |
29 Jan 24 | SellUS$53,555 | Nur Nicholson | Individual | 835 | US$64.14 | |
29 Jan 24 | SellUS$58,109 | Timothy Sullivan | Individual | 906 | US$64.14 | |
29 Jan 24 | SellUS$23,539 | Karen Lewis | Individual | 367 | US$64.14 | |
22 Jan 24 | SellUS$254,329 | Pascal Deschatelets | Individual | 3,913 | US$65.00 | |
22 Jan 24 | SellUS$221,831 | Adam Townsend | Individual | 3,413 | US$65.00 | |
22 Jan 24 | SellUS$271,943 | David Watson | Individual | 4,184 | US$65.00 | |
22 Jan 24 | SellUS$112,963 | Karen Lewis | Individual | 1,738 | US$65.00 | |
22 Jan 24 | SellUS$168,535 | Nur Nicholson | Individual | 2,593 | US$65.00 | |
22 Jan 24 | SellUS$230,801 | Timothy Sullivan | Individual | 3,551 | US$65.00 | |
22 Jan 24 | SellUS$89,954 | Mark Delong | Individual | 1,384 | US$65.00 | |
22 Jan 24 | SellUS$68,961 | James Chopas | Individual | 1,061 | US$65.00 | |
22 Jan 24 | SellUS$104,449 | Jeffrey Eisele | Individual | 1,607 | US$65.00 | |
22 Jan 24 | SellUS$872,961 | Cedric Francois | Individual | 13,431 | US$65.00 | |
16 Jan 24 | SellUS$524,514 | Cedric Francois | Individual | 7,851 | US$66.81 | |
16 Jan 24 | SellUS$109,032 | Karen Lewis | Individual | 1,632 | US$66.81 | |
16 Jan 24 | SellUS$149,317 | Timothy Sullivan | Individual | 2,235 | US$66.81 | |
16 Jan 24 | SellUS$124,064 | Nur Nicholson | Individual | 1,857 | US$66.81 | |
16 Jan 24 | SellUS$109,032 | Pascal Deschatelets | Individual | 1,632 | US$66.81 | |
16 Jan 24 | SellUS$149,317 | Adam Townsend | Individual | 2,235 | US$66.81 | |
16 Jan 24 | SellUS$283,268 | David Watson | Individual | 4,240 | US$66.81 | |
16 Jan 24 | SellUS$29,262 | Jeffrey Eisele | Individual | 438 | US$66.81 | |
16 Jan 24 | SellUS$108,965 | Mark Delong | Individual | 1,631 | US$66.81 | |
16 Jan 24 | SellUS$57,723 | James Chopas | Individual | 864 | US$66.81 | |
04 Jan 24 | SellUS$165,207 | Caroline Baumal | Individual | 2,751 | US$60.05 | |
26 Dec 23 | SellUS$3,935 | Jeffrey Eisele | Individual | 68 | US$57.86 | |
01 Dec 23 | SellUS$1,467,240 | Epidarex Capital | Company | 24,000 | US$61.14 | |
21 Nov 23 | SellUS$244,000 | Cedric Francois | Individual | 5,000 | US$48.80 | |
17 Nov 23 | SellUS$444,620 | A. Dunlop | Individual | 8,894 | US$49.99 | |
23 Oct 23 | SellUS$6,031 | Mark Delong | Individual | 131 | US$46.04 | |
23 Oct 23 | SellUS$6,077 | James Chopas | Individual | 132 | US$46.04 | |
17 Oct 23 | SellUS$1,176,000 | Epidarex Capital | Company | 24,000 | US$49.00 |
Volumen des Insiderhandels
Insider-Käufe: APLS Die Insider haben nur in den letzten 3 Monaten Aktien verkauft.
Aufschlüsselung der Eigentumsverhältnisse
Typ des Eigentümers | Anzahl der Aktien | Eigentumsanteil in Prozent |
---|---|---|
Staat oder Regierung | 45.445 | 0,0338 % |
Einzelne Insider | 4.367.403 | 3,25 % |
VC/PE-Firmen | 12.806.342 | 9,52 % |
Hedge-Fonds | 22.718.536 | 16,9 % |
Einrichtungen | 94.640.002 | 70,3 % |
Verwässerung von Anteilen: Die Aktionäre wurden im vergangenen Jahr verwässert, wobei die Zahl der ausstehenden Aktien um 4.2% stieg.
Top-Aktionäre
Eigentümerschaft | Name | Aktien | Aktueller Wert | Veränderung in % | Portfolio % | |
---|---|---|---|---|---|---|
16.388.697 | US$483.0m | 8,84 % | 0,07 % | |||
12.806.342 | US$377.4m | 0 % | 83,92 % | |||
11.607.425 | US$342.1m | 2,2 % | 10,87 % | |||
11.111.111 | US$327.4m | 0 % | 4,27 % | |||
9.809.552 | US$289.1m | 3,19 % | keine Daten | |||
5.795.272 | US$170.8m | 5,47 % | keine Daten | |||
5.324.838 | US$156.9m | -24,6 % | 0,01 % | |||
4.146.694 | US$122.2m | 42,5 % | keine Daten | |||
3.591.416 | US$105.8m | 10,8 % | 0,06 % | |||
3.299.742 | US$97.2m | 51,5 % | 0,01 % | |||
3.131.953 | US$92.3m | 46,9 % | 0,01 % | |||
2.880.880 | US$84.9m | 2,63 % | 13,67 % | |||
2.500.000 | US$73.7m | 150 % | 2,0 % | |||
2.016.220 | US$59.4m | 34,2 % | 0,01 % | |||
1.834.224 | US$54.1m | 0 % | keine Daten | |||
1.819.604 | US$53.6m | 14,2 % | 0,02 % | |||
1.787.917 | US$52.7m | 5,8 % | keine Daten | |||
1.726.000 | US$50.9m | 0 % | 2,61 % | |||
1.467.080 | US$43.2m | 11,5 % | 1,03 % | |||
1.401.190 | US$41.3m | 47,7 % | 0,09 % | |||
1.302.800 | US$38.4m | 0,39 % | 0,54 % | |||
1.113.897 | US$32.8m | 2,48 % | keine Daten | |||
1.084.514 | US$32.0m | 44,8 % | 0,01 % | |||
1.079.605 | US$31.8m | 14,1 % | keine Daten | |||
1.079.440 | US$31.8m | 2,37 % | 0,12 % |